Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-12-14
DOI
10.1093/jnci/dju366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
- (2013) E M Wever et al. BRITISH JOURNAL OF CANCER
- Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial
- (2013) Anna Grenabo Bergdahl et al. EUROPEAN UROLOGY
- Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis
- (2013) Andrew J Martin et al. MEDICAL JOURNAL OF AUSTRALIA
- A literature review of cost–effectiveness analyses of prostate-specific antigen test in prostate cancer screening
- (2013) Vishvas Garg et al. Expert Review of Pharmacoeconomics & Outcomes Research
- To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
- (2012) E M Wever et al. BRITISH JOURNAL OF CANCER
- The impact of PLCO control arm contamination on perceived PSA screening efficacy
- (2012) Roman Gulati et al. CANCER CAUSES & CONTROL
- Health-Related Quality of Life in the Finnish Trial of Screening for Prostate Cancer
- (2012) Neill Booth et al. EUROPEAN UROLOGY
- Quality of Life and Guidelines for PSA Screening
- (2012) Harold C. Sox NEW ENGLAND JOURNAL OF MEDICINE
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Prostate Specific Antigen Screening in the United States: Extrapolating From the European Study of Screening for Prostate Cancer
- (2011) Alex Shteynshlyuger et al. JOURNAL OF UROLOGY
- Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial
- (2011) Eva Johansson et al. LANCET ONCOLOGY
- How Does Early Detection by Screening Affect Disease Progression?
- (2011) Elisabeth M. Wever et al. MEDICAL DECISION MAKING
- Optimization of PSA Screening Policies
- (2011) Jingyu Zhang et al. MEDICAL DECISION MAKING
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
- (2010) Jonas Hugosson et al. LANCET ONCOLOGY
- Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
- (2009) E A M Heijnsdijk et al. BRITISH JOURNAL OF CANCER
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial
- (2008) A. Bill-Axelson et al. JNCI-Journal of the National Cancer Institute
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
- (2008) Martin G. Sanda et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started